Latest news
Loading news…
Outpace Bio
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Seattle, Washington, United States Founded 2020 51-100 employees For Profit
Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
65
Patents
16
5 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 44
- Patents granted
- 16
- Trademarks
- 5
- Top patent class
- Organic Chemistry
- IT spend
- $495K
Company Info
- Founded
- 2020
- Employees
- 51-100
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 33
- HQ
- Seattle, Washington, United States
- Region
- Greater Seattle Area, West Coast, Western US
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- -0.2
- Trend (30d)
- -0.2
- Trend (90d)
- 0.9
Key People at Outpace Bio
Chief Business Officer
Co-Founder, Chief Scientific Officer
Co-founder, Chief Executive Officer
65
professional contacts at Outpace Bio
Contact execs at Outpace Bio →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Outpace Bio
Loading news…
FAQs about Outpace Bio
People who checked this page also checked these
Browse the full Acquirezy directory.